Basic Information
Inscripta is a gene-editing technology company, formerly known as Muse Biotechnologies, dedicated to creating revolutionary gene-editing technologies and tools to bring transformation to human food, fuel, and healthcare. It is developing a family of CRISPR enzymes (called MADzymes) based on cutting-edge CRISPR gene-editing principles, which can be custom-designed for researchers and commercial partners to provide the required nucleases, along with a complete set of gene-editing supporting tools (software, instruments, reagents, etc.). These tools will significantly enhance the speed and efficiency of gene editing.
Inscripta, Inc
Colorado,United States of America
unclear
January 01, 2015
--

